Spanish scientists estimate that in 30 or 40 years there could be a cure for breast cancer due to the increase of the survival rates of patients with that affliction and the new treatments in that area.
Atanasio Pandiella, leading researcher of the Centre of Investigation of Cancer in Salamanca made the statement today during a press conference. Meanwhile the director of
CIC, Eugenio Santos pointed out that the survival increment of patients has increased from 1 to 1,5% per year, along with the new discoveries. “There could be a cure.”
Pandiella is among the people responsible for the development of a new treatment based on a combination of drugs Herceptin and Dasatinib which according to lab results prevents tumor growths. This result was seen on patients with a bad prognosis, which represents the 30% of most cases.
So far the treatment for this type of tumor is developed with Herceptin. “Although this means an improvement in therapies, it is not effective on all patients.” Pandiella added.
The combination of these two drugs considerably increases the prevention of tumor growths, the cells of the tumor consists on high levels of HER2 and the treatments continue to be developed.
Currently a clinical trial is being prepared with the collaboration of national oncologists who will intervene around 40 patients. If the results are positive it is possible that an international trial is performed with the help of world experts and the powerful pharmaceutical companies of United Estates.